Protease inhibition as new therapeutic strategy for GI diseases
Nathalie Vergnolle(Inserm)
Cited by 219
Related Papers
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
|Nature Medicine|2000|931
Protease-Activated Receptor 2 Sensitizes the Capsaicin Receptor Transient Receptor Potential Vanilloid Receptor 1 to Induce Hyperalgesia
|Journal of Neuroscience|2004|409
Protease‐activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice
|The Journal of Physiology|2006|388
Elafin and its precursor trappin‐2: What is their therapeutic potential for intestinal diseases?
|British Journal of Pharmacology|2022|21